|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3750 AUD | -1.32% |
|
+1.35% | -42.31% |
| 07-30 | Recce Pharmaceuticals in Position to Benefit from US ASPR Medical Countermeasures Strategy | MT |
| 07-21 | Recce Pharmaceuticals Reports Higher Cash Balance in June Quarter | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.32% | +1.35% | 0.00% | -25.00% | -42.31% | 0.00% | -46.43% | -58.79% | +36.36% | 79.31M | |
| -0.52% | +3.21% | -2.57% | +25.02% | +10.33% | +89.52% | +125.32% | +343.82% | +1,354.86% | 1,057B | |
| +0.88% | +1.13% | +0.05% | +17.13% | +25.27% | +49.56% | +49.79% | +49.24% | +110.03% | 625B | |
| +0.89% | -1.95% | -1.55% | +22.07% | +7.68% | +24.23% | +63.19% | +115.71% | +268.54% | 435B | |
| +0.71% | +3.87% | +9.48% | +16.49% | +11.91% | +49.07% | +38.29% | +1.37% | +47.63% | 363B | |
| +0.64% | -0.49% | +1.35% | +11.13% | +14.95% | +33.94% | +38.94% | +48.82% | +54.86% | 296B | |
| +0.39% | -5.83% | -10.92% | -10.85% | -13.73% | +8.92% | +6.39% | +45.16% | +129.79% | 249B | |
| +1.51% | +6.69% | +13.01% | +23.89% | +25.55% | +42.58% | +58.47% | +80.33% | +138.81% | 222B | |
| +3.92% | -0.46% | -4.70% | +5.10% | -6.20% | -5.56% | -51.70% | -4.18% | +88.04% | 209B | |
| +1.80% | +2.30% | -1.21% | +1.43% | +8.53% | +11.56% | +66.16% | +94.58% | +67.92% | 165B | |
| +2.14% | +7.00% | +10.35% | +4.21% | +7.47% | +8.87% | -25.33% | -41.80% | -23.72% | 153B | |
| +0.89% | -0.90% | +11.70% | +15.24% | +19.99% | +40.85% | +6.76% | -3.95% | +5.05% | 132B | |
| +2.49% | +3.98% | -0.09% | +15.41% | +9.42% | +35.34% | +43.74% | +147.54% | +382.42% | 126B | |
| +1.24% | +1.50% | +0.05% | +6.38% | +7.45% | +40.49% | +41.70% | +8.29% | -6.92% | 106B | |
| +1.35% | +1.13% | -1.53% | +3.02% | -8.96% | -6.94% | -22.03% | -13.49% | +3.09% | 104B | |
| +1.01% | +3.41% | -6.41% | -13.05% | -16.11% | +11.91% | +62.10% | +69.65% | +476.25% | 71.54B | |
| +0.83% | +3.66% | -1.76% | +34.69% | +34.59% | +93.70% | -4.25% | +5.52% | -49.60% | 56.57B | |
| +0.04% | +2.55% | +3.49% | +7.44% | +14.71% | +27.64% | +24.57% | +53.08% | +16.41% | 56.09B | |
| +4.82% | +1.00% | +1.13% | +3.45% | -8.31% | -10.44% | +36.07% | -0.33% | +237.08% | 53.41B | |
| -0.32% | +1.68% | +2.55% | +11.53% | -1.44% | +4.00% | +12.40% | - | - | 43.91B | |
| Average | +1.16% | +1.39% | +1.12% | +8.74% | +5.04% | +27.46% | +26.21% | +49.50% | +175.63% | 226.16B | |
| Weighted average by Cap. | +0.83% | +1.38% | +0.50% | +14.96% | +10.42% | +43.88% | +53.92% | +116.68% | +409.29% |
- Stock Market
- Stocks
- RCE Stock
- Sector Recce Pharmaceuticals Ltd
Select your edition
All financial news and data tailored to specific country editions
